Neftaly: Strengthening Quality Assurance Systems at the National Drug Authority
Ensuring the safety, efficacy, and quality of medicines and medical products is vital for protecting public health. The National Drug Authority (NDA) plays a critical role in regulating pharmaceuticals, medical devices, and health products to safeguard the population.
Neftaly (South African Youth Project) is dedicated to strengthening the quality assurance (QA) systems at the NDA to enhance regulatory oversight, improve compliance, and ensure that only safe and effective products reach the market.
Program Goal
To strengthen the National Drug Authority’s quality assurance systems for enhanced regulation, inspection, testing, and monitoring of medicines and health products in the country.
Strategic Objectives
- Enhance the technical and operational capacity of the NDA to enforce QA standards consistently.
- Improve pharmacovigilance and post-market surveillance systems to detect and respond to substandard or counterfeit products.
- Strengthen laboratory testing infrastructure and protocols for medicine quality control.
- Promote compliance with national and international pharmaceutical regulations and best practices.
Key Intervention Areas
1. Regulatory Framework and Standards
- Review and update QA guidelines, SOPs, and regulatory frameworks to align with global standards.
- Support the development of clear inspection and certification processes for manufacturers, distributors, and importers.
2. Capacity Building and Training
- Train NDA staff on good manufacturing practices (GMP), quality control, inspection techniques, and risk-based approaches.
- Strengthen the skills of laboratory personnel in advanced analytical testing methods.
3. Laboratory Strengthening
- Upgrade laboratory facilities and equip them with modern technologies for accurate and timely quality testing.
- Establish quality management systems (QMS) in NDA laboratories to ensure reliable results.
4. Pharmacovigilance and Post-Market Surveillance
- Develop and implement systems for reporting, investigating, and responding to adverse drug reactions and substandard products.
- Engage healthcare providers, pharmacies, and the public in vigilance reporting and awareness.
5. Stakeholder Engagement and Collaboration
- Foster partnerships with manufacturers, health facilities, and international regulatory bodies to enhance compliance and knowledge sharing.
- Promote public awareness campaigns on medicine safety and quality.
Expected Outcomes
- Robust QA systems ensuring consistent enforcement of pharmaceutical quality standards.
- Improved detection and removal of counterfeit and substandard medicines from the market.
- Enhanced laboratory capacity providing reliable and timely quality testing results.
- Increased public confidence in the safety and efficacy of medicines.
Why It Matters
Strengthening the NDA’s quality assurance systems protects public health by ensuring that only safe, effective, and high-quality medicines are available to the population. This reduces treatment failures, drug resistance, and adverse health outcomes.
Partner with Neftaly
Neftaly is committed to empowering regulatory authorities like the NDA to uphold stringent quality standards for medicines and health products, safeguarding communities and strengthening health systems.